This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Daniel R., Kaul, , United States
Authors: Daniel R. Kaul
Overview
While uncommon, donor derived infections may result in significant recipient morbidity and mortality. Early recognition is critical for successful treatment of the affected recipient and the possible application of preventative therapy to other exposed recipients of the same donor. Serological and now nucleic acid screening of donors has markedly reduced the risk of transmission of blood borne viruses such as hepatitis B and C, and HIV. Ongoing challenges include parasites, fungi, and multidrug resistant bacterial pathogens.
Objectives
1) Understand optimal living and deceased donor screening strategies to reduce the risk of donor derived infection.
2) Recognize the typical time course and other presenting features of donor-derived infection.
3) Understand emerging pathogens associated with donor-derived infection.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada